Over the weekend, Kite Pharma, Inc., (Nasdaq: KITE) today announced two plenary presentations of positive data from the primary analysis ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE